Date & Location
Saturday, September 30, 2023, 8:00 AM - 3:10 PM, 
Cedars-Sinai Medical Center, Los Angeles, CA

Target Audience
Specialties - Hematology, Imaging, Internal Medicine, Oncology, Pathology & Laboratory Medicine, Radiation Oncology, Radiology, Surgery
Professions - Nurse, Nurse Practitioner, Physician, Researcher (physician)

Overview
This conference will provide a chance for southern California lymphoma specialists to gather and discuss updates and advancements in lymphoma treatment and research, including an overview and summary of the main points from the American Society of Hematology (ASH) and the American Society for Transplantation and Cellular Therapy (ASTCT). We will also discuss the future of lymphoma treatment and the current external environment.

Objectives

1. Recognize the utility of molecular testing in the classification and treatment of lymphoma
2. Identify current evidence based treatments for Hodgkin lymphoma, diffuse large B-cell lymphoma, and peripheral T-cell lymphoma
3. Describe new treatments under development including bi-specific antibodies and CART therapies